Higher DHA Levels Associated With Reduced Risk Of Alzheimer's Disease.
FL, 11 November 2003
from a new study conducted at Tufts University suggest that having
increased docosahexaenoic acid (DHA) levels in the blood and eating
about three fish meals each week are associated with a significant
48 percent reduction in the risk of Alzheimer's disease in elderly
men and women.
at Tufts University in Boston measured the fatty acid content of
plasma obtained from 1137 men and women with a mean age of 75 who
were part of the Framingham Heart Study. The subjects' diets were
assessed by questionnaire and those free of dementia were followed
for a mean of 10 years. During the study they were assessed for
the onset of new dementia including Alzheimer's Disease.
who had diets rich in DHA, an omega-3 fatty acid, reduced their
risk of developing dementia considerably compared with those whose
diets contained low amounts of DHA. These results are consistent
with a study published in Archives of Neurology in July 2003.
dramatic results show how older adults can play a significant role
in their neurological health by increasing their intake of fish,
fish oil or especially, DHA," said Ernst Schaefer, MD, senior scientist
and director of the Lipid Metabolism Laboratory at Tufts University.
now there have been only two predictors for Alzheimer's Disease,
age and genotype," stated Henry "Pete" Linsert, Jr, Chairman and
CEO of Martek. "This study suggests that low dietary intake of DHA
may be a risk factor for Alzheimer's Disease. Martek looks forward
to additional research to provide more evidence on this possible
or docosahexaenoic acid, is the most abundant fatty acid in the
brain. Besides a diet that includes fish, another way to obtain
DHA is by supplementation. Martek Biosciences manufactures a DHA
supplement under the brand name Neuromins® which is free of
oceanic contaminants that may be found in some fish and fish oil.
For more information on DHA, visit www.DHADepot.com.
Biosciences Corporation develops and sells products from microalgae.
The Nutritional Products Group manufactures and sells two nutritional
fatty acids, docosahexaenoic acid (DHA) and arachidonic acid (ARA).
Martek has patented its DHA (DHASCO®) and ARA (ARASCO®)
oil blend (Formulaid®) and sells it to infant formula manufacturers
worldwide. Martek also sells its DHA oil, under the Neuromins®
brand name, to the nutritional supplement industry, either directly
or through a number of supplement manufacturers. The Fluorescent
Products Group develops and sells a series of proprietary and non-proprietary
fluorescent markers. These markers have been designed for use in
a wide range of drug discovery and research applications.
Biosciences Corporation (www.martekbio.com).